摘要 |
<p>The invention relates to a novel group of compounds of Formula (I) or a salt thereof: wherein R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, n, A and HET-1 are as described in the specification, which may be useful in the treatment or prevention of a disease or medical condition mediated through glucokinase (GLK) such as type 2 diabetes. The invention also relates to pharmaceutical compositions comprising said compounds, methods of treatment of diseases mediated by GLK using said compounds and methods for preparing compounds of Formula (I).</p> |
申请人 |
ASTRAZENECA AB;ASTRAZENECA UK LIMITED;MARTIN, NATHANIEL, GEORGE;MCKERRECHER, DARREN;PIKE, KURT, GORDON;WARING, MICHAEL, JAMES |
发明人 |
MARTIN, NATHANIEL, GEORGE;MCKERRECHER, DARREN;PIKE, KURT, GORDON;WARING, MICHAEL, JAMES |